Parabilis Medicines: Series FDevelops medicines targeting historically undruggable protein targets in cancerOct 4, 2026RoundOSParabilis MedicinesCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries C+